In contrast, some melatonergic genes were significantly overexpressed during cancer progression and were opposite to their differentially expressed status between cancerous and normal samples (e.g., RORB in COAD, KIRC, and STAD; CALM1 in BRCA; CYP1A2 in LUSC). This evidence concerns the gene RORB and colon adenocarcinoma.